reported that the relevant locus for the dre1(discs lost) complementation group is CG12021, based on mapping and complementation data shown in Figure 4 of the paper. CG12021 encodes a homolog of the mammalian PDZ protein Patj. However, based on the most current annotation in FlyBase, the 9-10 kb deficiency (Df(3L)MY10) that was generated to remove the CG12021 transcript affects not just two transcripts (Cdc37 and CG12021) as originally documented, but rather seven genes including vanaso (CG32315) located approximately 5 kb upstream to CG12021 (Figure 1 (below) , FlyBase). Recently, it was indicated to us by Dr. Christian Klambt and his colleagues (Pielage et al., 2003) that dre1, the mutation that we claimed to be responsible for the documented phenotype, is allelic to CG32315, rather than CG12021. We therefore re-evaluated our data and discovered the following: sequencing of the CG12021 gene identified a threonine to serine transition at amino acid 516 as well as a stop codon in CG32315 at nucleotide position 865. Since the mutation in CG12021 is a conservative amino acid change, it may not underlie the loss of imaginal discs observed in dre1. Rather, the dre1 phenotypes we described are likely due to the mutation in CG32315. This is supported by the observation that a critical genomic rescue construct named dlt EHHS (Figure 4 of Bhat et al.) now failed to rescue the dre1 mutation in our assays. This result combined with the other rescue data, the stop codon mutation in CG32315, and the failure of dre1 mutation to complement a vanaso allele (van 04276 ) obtained from the Bloomington Stock Center, clearly implicates CG32315 as causing the lethality associated with dre1. However, we do not exclude the possibility that dre1 phenotypes documented in Figure 6 of Bhat et al. (1999), which we confirmed, may result from a combination of mutations in both genes. Indeed, we also confirmed that overexpression of CG12021 causes a severe loss of epithelial polarity as shown in Figure 7 (Bhat et al., 1999) . Hence, based on these observations, the phenotype of CG12021-specific mutations remains to be determined.
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We also repeated the biochemical interaction between Crb and the protein encoded by CG12021 shown in Figure 3N 
